Related references
Note: Only part of the references are listed.Animal studies supporting the inhibition of mast cell activation byEriobotrya japonicaseed extract
Masahide Onogawa et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2009)
Effect of Eriobotrya japonica seed extract on 5-fluorouracil-induced mucositis in hamsters
Daisuke Takuma et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Gastroprotective activity of Eriobotrya japonica seed extract on experimentally induced gastric lesions in rats
Junko Yokota et al.
JOURNAL OF NATURAL MEDICINES (2008)
Effect of orally administered Eriobotrya japonica seed extract on allergic contact dermatitis in rats
Guangchen Sun et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis
James E. Nelson et al.
HEPATOLOGY (2007)
Angiotensin II type I receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis
Akira Hirose et al.
HEPATOLOGY (2007)
α1-Antitrypsin mutations in NAFLD:: High prevalence and association with altered iron metabolism but not with liver damage
Luca Valenti et al.
HEPATOLOGY (2006)
Scavenging of reactive oxygen species by Eriobotrya japonica seed extract
J Yokota et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Liver failure caused by non-alcoholic steatohepatitis in an obese young male
D Suzuki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis
TH Le et al.
HEPATOLOGY (2004)
The effect of Eriobotrya japonica seed extract on oxidative stress in adriamycin-induced nephropathy in rats
A Hamada et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background
S Kojima et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Hepatic cytochrome p450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis
N Chalasani et al.
HEPATOLOGY (2003)
Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region?
GC Farrell
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Nonalcoholic fatty liver disease: An agenda for clinical research
ZM Younossi et al.
HEPATOLOGY (2002)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
Share Paper
